NVIV logo

NVIV Cash From Investing

Annual CFI

-$160.00 K
-$83.00 K-107.79%

December 31, 2022

Summary

Performance

1-Year Change

-107.79%

3-Year Change

-1233.33%

5-Year Change

-101.39%

15-Year Change

-101.39%

NVIV Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$11.51 M
NVIV annual cash flow from investing activities is currently -101.39% below its historical high of $11.51 million

3-Year Low

-$160.00 K
NVIV annual cash flow from investing activities is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
NVIV previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
NVIV next annual earnings announcement has not yet been scheduled

OtherNVIVcash flowmetrics:

Annual CFF

$7.96 M
NVIV annual cash flow from financing activities is $7.96 million

Annual CFO

-$10.48 M
NVIV annual cash flow from operations is -$10.48 million

Annual FCF

-$10.64 M
NVIV annual free cash flow is -$10.64 million

Annual CAPEX

-
NVIV annual capital expenditures value is unknown

Quarterly CFI

$43.00 K
+$21.00 K+95.45%

September 30, 2023

Summary

Performance

3-Month Change

+95.45%

1-Year Change

+170.49%

3-Year Change

+960%

5-Year Change

+100%

NVIV Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$6.80 M
NVIV quarterly cash flow from investing activities is currently -99.37% below its historical high of $6.80 million

3-Year Low

-$61.00 K

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2023
NVIV previous earnings announcement was published on Sep 30, 2023

Next Quarterly Earnings Report Date

N/A
NVIV next earnings announcement has not yet been scheduled

OtherNVIVcash flowmetrics:

Quarterly CFF

-
NVIV quarterly cash flow from financing activities value is unknown

Quarterly CFO

-$2.28 M
NVIV quarterly cash flow from operations is -$2.28 million

Quarterly FCF

-$2.28 M
NVIV quarterly free cash flow is -$2.28 million

Quarterly CAPEX

-
NVIV quarterly capital expenditures value is unknown

TTM CFI

$50.00 K
+$104.00 K+192.59%

September 30, 2023

Summary

Performance

3-Month Change

+192.59%

1-Year Change

+124.75%

3-Year Change

+225%

5-Year Change

+516.67%

NVIV TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$12.36 M
NVIV TTM cash flow from investing activities is currently -99.60% below its historical high of $12.36 million

3-Year Low

-$202.00 K

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2023
NVIV previous earnings announcement was published on Sep 30, 2023

Next Quarterly Earnings Report Date

N/A
NVIV next earnings announcement has not yet been scheduled

OtherNVIVcash flowmetrics:

TTM CFF

-
NVIV TTM cash flow from financing activities value is unknown

TTM CFO

-$10.13 M
NVIV TTM cash flow from operations is -$10.13 million

TTM FCF

-$10.17 M
NVIV TTM free cash flow is -$10.17 million

TTM CAPEX

-
NVIV TTM capital expenditures value is unknown

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

NVIV Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-107.8%+170.5%+124.8%
3 y3 years-1233.3%+960.0%+225.0%
5 y5 years-101.4%+100.0%+516.7%

NVIV Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year+107.8%at lowat high-241.9%at high-504.0%
5 y5-year+1233.3%at lowat high-241.9%at high-504.0%
alltimeall time-101.4%+3967.5%-99.4%<-9999.0%-99.6%<-9999.0%

InVivo Therapeutics Holdings Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2023
-
$43.00 K(+95.5%)
$50.00 K(-192.6%)
Jun 2023
-
$22.00 K(+1000.0%)
-$54.00 K(-59.1%)
Mar 2023
-
$2000.00(-111.8%)
-$132.00 K(-17.5%)
Dec 2022
-$160.00 K(+107.8%)
-$17.00 K(-72.1%)
-$160.00 K(-20.8%)
Sep 2022
-
-$61.00 K(+8.9%)
-$202.00 K(+27.0%)
Jun 2022
-
-$56.00 K(+115.4%)
-$159.00 K(+54.4%)
Mar 2022
-
-$26.00 K(-55.9%)
-$103.00 K(+33.8%)
Dec 2021
-$77.00 K(+87.8%)
-$59.00 K(+227.8%)
-$77.00 K(+148.4%)
Sep 2021
-
-$18.00 K(<-9900.0%)
-$31.00 K(+72.2%)
Jun 2021
-
$0.00(0.0%)
-$18.00 K(-56.1%)
Mar 2021
-
$0.00(-100.0%)
-$41.00 K(0.0%)
Dec 2020
-$41.00 K(+241.7%)
-$13.00 K(+160.0%)
-$41.00 K(+2.5%)
Sep 2020
-
-$5000.00(-78.3%)
-$40.00 K(+14.3%)
Jun 2020
-
-$23.00 K(+91.7%)
-$35.00 K(+191.7%)
Dec 2019
-$12.00 K(-81.5%)
-$12.00 K(<-9900.0%)
-$12.00 K(<-9900.0%)
Sep 2019
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2019
-
$0.00(0.0%)
$0.00(-100.0%)
Dec 2018
-$65.00 K(-100.6%)
$0.00(0.0%)
-$65.00 K(-109.9%)
Sep 2018
-
$0.00(-100.0%)
$657.00 K(-91.2%)
Jun 2018
-
-$90.00 K(-460.0%)
$7.46 M(-39.7%)
Mar 2018
-
$25.00 K(-96.5%)
$12.36 M(+7.4%)
Dec 2017
$11.51 M(-276.9%)
$722.00 K(-89.4%)
$11.51 M(+1.7%)
Sep 2017
-
$6.80 M(+41.2%)
$11.31 M(-628.7%)
Jun 2017
-
$4.82 M(-682.5%)
-$2.14 M(-71.8%)
Mar 2017
-
-$827.00 K(-257.5%)
-$7.59 M(+16.7%)
Dec 2016
-$6.51 M
$525.00 K(-107.9%)
-$6.51 M(-47.1%)
Sep 2016
-
-$6.66 M(+946.4%)
-$12.31 M(+117.6%)
DateAnnualQuarterlyTTM
Jun 2016
-
-$636.00 K(-346.5%)
-$5.66 M(+12.7%)
Mar 2016
-
$258.00 K(-104.9%)
-$5.02 M(-4.9%)
Dec 2015
-$5.28 M(>+9900.0%)
-$5.28 M(>+9900.0%)
-$5.28 M(<-9900.0%)
Sep 2015
-
-$2000.00(<-9900.0%)
$10.00 K(+233.3%)
Jun 2015
-
$0.00(0.0%)
$3000.00(-90.9%)
Mar 2015
-
$0.00(-100.0%)
$33.00 K(-1750.0%)
Dec 2014
-$2000.00(-99.7%)
$12.00 K(-233.3%)
-$2000.00(-98.2%)
Sep 2014
-
-$9000.00(-130.0%)
-$112.00 K(-12.5%)
Jun 2014
-
$30.00 K(-185.7%)
-$128.00 K(-65.8%)
Mar 2014
-
-$35.00 K(-64.3%)
-$374.00 K(-50.1%)
Dec 2013
-$749.00 K(-65.0%)
-$98.00 K(+292.0%)
-$749.00 K(-30.8%)
Sep 2013
-
-$25.00 K(-88.4%)
-$1.08 M(-57.0%)
Jun 2013
-
-$216.00 K(-47.3%)
-$2.51 M(+0.2%)
Mar 2013
-
-$410.00 K(-5.0%)
-$2.51 M(+17.2%)
Dec 2012
-$2.14 M(+667.7%)
-$431.50 K(-70.4%)
-$2.14 M(+22.6%)
Sep 2012
-
-$1.46 M(+590.9%)
-$1.75 M(+446.3%)
Jun 2012
-
-$210.90 K(+409.4%)
-$319.70 K(+91.8%)
Mar 2012
-
-$41.40 K(+12.2%)
-$166.70 K(-40.2%)
Dec 2011
-$278.90 K(+90.6%)
-$36.90 K(+21.0%)
-$278.90 K(+15.2%)
Sep 2011
-
-$30.50 K(-47.3%)
-$242.00 K(+14.4%)
Jun 2011
-
-$57.90 K(-62.3%)
-$211.50 K(+37.7%)
Mar 2011
-
-$153.60 K(<-9900.0%)
-$153.60 K(<-9900.0%)
Dec 2010
-$146.30 K(<-9900.0%)
-
-
Dec 2007
-
$0.00(0.0%)
$0.00(0.0%)
Sep 2007
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2007
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2007
$0.00
$0.00(0.0%)
$0.00(0.0%)
Dec 2006
-
$0.00
$0.00

FAQ

  • What is InVivo Therapeutics Holdings annual cash flow from investing activities?
  • What is the all time high annual CFI for InVivo Therapeutics Holdings?
  • What is InVivo Therapeutics Holdings annual CFI year-on-year change?
  • What is InVivo Therapeutics Holdings quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for InVivo Therapeutics Holdings?
  • What is InVivo Therapeutics Holdings quarterly CFI year-on-year change?
  • What is InVivo Therapeutics Holdings TTM cash flow from investing activities?
  • What is the all time high TTM CFI for InVivo Therapeutics Holdings?
  • What is InVivo Therapeutics Holdings TTM CFI year-on-year change?

What is InVivo Therapeutics Holdings annual cash flow from investing activities?

The current annual CFI of NVIV is -$160.00 K

What is the all time high annual CFI for InVivo Therapeutics Holdings?

InVivo Therapeutics Holdings all-time high annual cash flow from investing activities is $11.51 M

What is InVivo Therapeutics Holdings annual CFI year-on-year change?

Over the past year, NVIV annual cash flow from investing activities has changed by -$83.00 K (-107.79%)

What is InVivo Therapeutics Holdings quarterly cash flow from investing activities?

The current quarterly CFI of NVIV is $43.00 K

What is the all time high quarterly CFI for InVivo Therapeutics Holdings?

InVivo Therapeutics Holdings all-time high quarterly cash flow from investing activities is $6.80 M

What is InVivo Therapeutics Holdings quarterly CFI year-on-year change?

Over the past year, NVIV quarterly cash flow from investing activities has changed by +$104.00 K (+170.49%)

What is InVivo Therapeutics Holdings TTM cash flow from investing activities?

The current TTM CFI of NVIV is $50.00 K

What is the all time high TTM CFI for InVivo Therapeutics Holdings?

InVivo Therapeutics Holdings all-time high TTM cash flow from investing activities is $12.36 M

What is InVivo Therapeutics Holdings TTM CFI year-on-year change?

Over the past year, NVIV TTM cash flow from investing activities has changed by +$252.00 K (+124.75%)